(Q44050414)

29 November 2017

title

Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma (English)

1 reference

29 November 2017

Forrest DL

1

1 reference

29 November 2017

Thompson K

2

1 reference

29 November 2017

Nevill TJ

3

1 reference

29 November 2017

Couban S

4

1 reference

29 November 2017

Fernandez LA

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Bone Marrow Transplantation

29 November 2017

published in

1 reference

29 November 2017

volume

29

1 reference

29 November 2017

issue

12

1 reference

29 November 2017

page(s)

973-978

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703573

29 November 2017

exact match

0 references

cites work

Follicular lymphoma: have we made any progress?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Allogeneic transplantation for low-grade lymphoma: long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703573

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703573

1 reference

29 November 2017

1 reference